Anthony Dyer

No más puestos en curso

54 años

Consumer Services

Health Technology

Electronic Technology

Perfil

Anthony Dyer served as Director & Chief Corporate Development Officer at Novacyt SAS from 2021 to 2021.
Prior to that, he was Director at Microgen Bioproducts Ltd. from 2014 to 2021.
He will serve as CFO & Non-Executive Director at Love Hemp Group Plc from 2022 to 2023.
Dyer completed his undergraduate degree at the University of East Anglia.

Antiguos cargos conocidos de Anthony Dyer.

Empresas	Cargo	Fin
Love Hemp Group Plc Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry	Director Financiero/CFO	20/01/2023
NOVACYT	Director Financiero/CFO	05/01/2021
Microgen Bioproducts Ltd. Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing	Director/Miembro de la Junta	01/04/2021

Ver el detalle de la experiencia de Anthony Dyer.

Formación de Anthony Dyer.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Anthony Dyer.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
University of East Anglia University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novacyt SAS Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases	Health Technology
Microgen Bioproducts Ltd. Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing	Electronic Technology
Love Hemp Group Plc Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry	Finance